tirzepatide indications fda Big update in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA-approved for children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ A recent post hoc analysis

Can I get these medications just for weight loss, or only for diabetes

Physicians certified by the Canadian Board of Obesity Medicine have completed additional training in the complex biology of weight regulation and the nuances of pharmacological treatment

28,29 Semaglutide was associated with significant reductions in weight against the comparator across SUSTAIN 15 program: 3.5 to 4.3 kg for the 0.5 mg dose and 4.5 to 6.4 kg with the 1 mg weekly dose (Figure 3)

Monjauro Mounjaro, FDA-approved in 2022 for the treatment of type 2 diabetes, is one of Eli Lillys most widely discussed drugs due to its reported weight loss benefits

Evidence quality assessment Strong evidence: BPC-157 accelerates tendon healing in rats (multiple independent studies, consistent results, large effect sizes)